Effective dose of remimazolam co-administered with remifentanil to facilitate I-gel insertion without neuromuscular blocking agents: an up-and-down sequential allocation trial

BACKGROUND: Remimazolam is a new anesthetic drug developed and is an ultra-short-acting agent with rapid onset and offset. The pharmacology of this drug seems to be ideal for short surgeries eligible for I-gel insertion. Therefore, this study aimed to determine the optimal bolus dose of remimazolam...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Juyeon, Park, Sung Yong, Lee, Ga Yun, Park, Ji Hyun, Joe, Han Bum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018909/
https://www.ncbi.nlm.nih.gov/pubmed/36927413
http://dx.doi.org/10.1186/s12871-023-02041-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018909/
https://www.ncbi.nlm.nih.gov/pubmed/36927413
http://dx.doi.org/10.1186/s12871-023-02041-z

Ejemplares similares